ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | +1900.0% | 14,946 | +1930.7% | 0.00% | – |
| Q2 2023 | $1 | -93.8% | 736 | -74.7% | 0.00% | – |
| Q1 2023 | $16 | -100.0% | 2,911 | -81.2% | 0.00% | – |
| Q3 2022 | $219,000 | +812.5% | 15,454 | +1162.6% | 0.00% | – |
| Q1 2022 | $24,000 | -91.9% | 1,224 | -92.8% | 0.00% | – |
| Q4 2021 | $295,000 | +2581.8% | 16,895 | +1307.9% | 0.00% | – |
| Q3 2021 | $11,000 | -8.3% | 1,200 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |